| Item | Value |
|---|---|
| DrugBank ID | DB00501 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | dyspepsia | TxGNN Knowledge Graph |
| 2 | gastroesophageal reflux disease | TxGNN Knowledge Graph |
| 3 | multiple endocrine neoplasia | TxGNN Knowledge Graph |
| 4 | duodenal ulcer (disease) | TxGNN Knowledge Graph |
| 5 | hyperinsulinism (disease) | TxGNN Knowledge Graph |
| 6 | mastocytosis | TxGNN Knowledge Graph |
| 7 | gastrin secretion abnormality | TxGNN Knowledge Graph |
| 8 | systemic mastocytosis | TxGNN Knowledge Graph |
| 9 | Zollinger-Ellison syndrome | TxGNN Knowledge Graph |
| 10 | esophagitis (disease) | TxGNN Knowledge Graph |
| 11 | gastric ulcer (disease) | TxGNN Knowledge Graph |
| 12 | peptic esophagitis | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.